Zobrazeno 1 - 10
of 31
pro vyhledávání: '"Marta A. Miyares"'
Autor:
Joseph E Mazur, Melissa E Badowski, Simon W. Lam, Lucas T Schulz, Sarah M Michienzi, Marta A. Miyares
Publikováno v:
Hospital Pharmacy. 52:33-43
Research offers an opportunity for investigators to explore unanswered questions, highlight best practices, and engage in collaboration. Clinical research can engage health care professionals to identify treatments or procedures to enhance patient ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09ae9278fed5f2e1d0501933983a5b49
https://doi.org/10.1310/hpj5201-33
https://doi.org/10.1310/hpj5201-33
Publikováno v:
American Journal of Health-System Pharmacy. 72:1623-1629
Purpose The safety and efficacy of dual antiplatelet therapy (DAPT) with aspirin and clopidogrel in the setting of secondary stroke prevention are reviewed. Summary Antiplatelet therapy has been shown to reduce the risk of numerous vascular events, e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2685bd8c9ae218363eda9533e091f7d0
https://doi.org/10.2146/ajhp140804
https://doi.org/10.2146/ajhp140804
Autor:
Maria Padron, Marta A. Miyares
Publikováno v:
Journal of Pharmacy Practice. 28:93-98
Pharmacist-directed anticoagulation management services (AMSs) have been shown to significantly lower anticoagulation-related mortality, length of hospital stay, bleeding complications, blood transfusion requirements, and cost of therapy. AMSs are on
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a7015f2e77b7084314761dcab2955e7b
https://doi.org/10.1177/0897190013514091
https://doi.org/10.1177/0897190013514091
Autor:
Marta A. Miyares
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 73(10)
Bayat and colleagues[1][1] should be applauded for their research on the early diagnosis of heparin-induced thrombocytopenia (HIT), in which they found that the combination of optical density (OD) values for antiheparin–platelet factor 4 (anti-PF4)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::21bbefe6f89a82837f3137eb14daea7e
https://pubmed.ncbi.nlm.nih.gov/27147210
https://pubmed.ncbi.nlm.nih.gov/27147210
Publikováno v:
Journal of pharmacy practice. 28(6)
Objective: To evaluate the role of idarucizumab, a humanized monoclonal antibody fragment, as a specific reversal agent for the anticoagulant activity of dabigatran and to review the pharmacology, pharmacokinetic properties, efficacy, and safety of t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a13fb28dfdc10b418c19ea0ed9a67be6
https://pubmed.ncbi.nlm.nih.gov/26894245
https://pubmed.ncbi.nlm.nih.gov/26894245
Publikováno v:
Journal of Pharmacy Practice. 26:438-441
A pharmacist-managed deep vein thrombosis (DVT) treatment program was put into operation at Jackson Memorial Hospital in Miami, Florida to provide appropriate transition of care to the outpatient setting for patients diagnosed with DVT. A postgraduat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b45fd1148dd346738c141d6da6ec3bb1
https://doi.org/10.1177/0897190012465953
https://doi.org/10.1177/0897190012465953
Autor:
Marta A. Miyares, Kyle A. Davis
Publikováno v:
Vascular Health and Risk Management
Cardiovascular disease (CVD) is responsible for significant morbidity and mortality within the United States and worldwide. Although targeting low-density lipoprotein cholesterol (LDL-C) in the prevention of CVD has been shown to be effective, eviden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6792650b81ba617a7be263a34018cb70
http://europepmc.org/articles/PMC3430392
http://europepmc.org/articles/PMC3430392
Autor:
Marta A. Miyares
Publikováno v:
Annals of Pharmacotherapy. 45:84-94
Objective To evaluate the role of cholesteryl ester transfer protein (CETP) in the cholesterol transport system and review the pharmacology, pharmacokinetic properties, efficacy, and adverse effects of the CETP inhibitors, anacetrapib and dalcetrapib
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cb2de52e3db76917a6923ba11f97653
https://doi.org/10.1345/aph.1p446
https://doi.org/10.1345/aph.1p446
Autor:
Cristina M. Salas, Marta A. Miyares
Publikováno v:
American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists. 72(11 Suppl 1)
Objective Heart failure (HF) is a leading cause of hospital readmissions adversely affecting resources and hospital reimbursements. The purpose of this study was to optimize medication therapy, provide patient education and facilitate discharge and f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b982c3b34f46c19a9505487ebcdff81
https://pubmed.ncbi.nlm.nih.gov/25991595
https://pubmed.ncbi.nlm.nih.gov/25991595
Autor:
Marta A. Miyares
Publikováno v:
The Annals of pharmacotherapy. 49(5)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fbd0eeb84343e222d88032e6591f7605
https://pubmed.ncbi.nlm.nih.gov/25870447
https://pubmed.ncbi.nlm.nih.gov/25870447